⌕
GSK · GSK · NYSE
Tenet 57 · Mixed
Compare
$50.45−0.38%At closeTenet 57 · Mixed
$50.45−0.19 (−0.38%)
At close: Nov 13, 2026, 4:00 PM ET· NYSE · USD
$50.46+0.01 (+0.02%)
After hours: Nov 13, 2026, 4:01 PM ET

GSK Stock

GSK closed at $50.45 on Nov 13, 2026; its Tenet Score is 57 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

4 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$50.45
Nov 13, 2026
Market cap
$108.9B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
14.2×
price ÷ earnings
Dividend yield
3.64%
past year's regular dividends ÷ price
52-week range
45.80 – 61.70
low → high
Tenet Score
57/100
Mixed · 409 Healthcare peers

Industry: Drugs · see every company filed here →

GSK Plc scores 57/100. Mixed. Strongest on quality and value, financial health is the soft spot, trading at 14× earnings versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
57/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
69
Quality
75
Health
29
Growth
56

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueCQualityBHealthFGrowthCMomentumD
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
6.3×
price to book value
P/S
2.5×
price to sales
ROE
59%
return on equity
Operating margin
24.3%
before interest and tax
Net margin
19.3%
of revenue kept
Current ratio
0.82
current assets to liabilities
Net debt / EBITDA
—
Not reported in the company's filings for this period.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.

The whole report, at a glance · every card is a live peek, click any to open the section

About GSK Plc

GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, th…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 39 US ETFs · top wrappers by weightSee all ETFs holding GSK →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

Compare GSK with

What sector and industry is GSK in?

GSK is in the Healthcare sector and the Drugs industry.

What is GSK's Tenet Score?

GSK's Tenet Score is 57 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.